Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Park, Man Seok
ROSUZET-AMI, NCT04499859: Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI	Recruiting	4	3548	RoW	Ezetimibe 10mg + Rosuvastatin 5mg, Rosuzet 10/5 mg, Rosuvastatin 20mg, Crestor 20mg	Kiyuk Chang, MD,PhD	Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity	01/24	07/24
RODIN, NCT05041010: Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz	Recruiting	3	496	RoW	Neu2000KWL group, Placebo group	GNT Pharma	Ischemic Stroke	06/24	01/25
Hur, Sung-Ho
IRIS SynergyXD, NCT05044273: Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent	Recruiting	N/A	1000	RoW	Synergy XD stent or Synergy Megatron™ Stent	Jung-min Ahn, CardioVascular Research Foundation, Korea	Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia, Coronary Disease	12/24	12/28